HPS3

protein-coding

HPS3 biogenesis of lysosomal organelles complex 2 subunit 1, the group of Biogenesis of lysosomal organelles complex 2

Gene summary

This gene encodes a protein containing a potential clathrin-binding motif, consensus dileucine signals, and tyrosine-based sorting signals for targeting to vesicles of lysosomal lineage. The encoded protein may play a role in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. Mutations in this gene are associated with Hermansky-Pudlak syndrome type 3. [provided by RefSeq, Apr 2015]

MANE transcript

NM_032383.5

Inheritance

AR

ClinVar variants

P:380U:381B:439

Top phenotype

Hermansky-Pudlak syndrome 3

gnomAD constraint

pLI —, LoF o/e 0.78

Max pathogenic AF

—

Genomic locus

chr3:149,129,638-149,173,732

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~44.1 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Hermansky-Pudlak syndrome without pulmonary fibrosisSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0016502

Submitter: Orphanet

Hermansky-Pudlak syndrome 3DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0013555

Submitter: ClinGen

The relationship between HPS3 and Hermasky-Pudlak syndrome 3, an autosomal recessive disorder, was evaluated using the ClinGen Clinical Validity Framework as of August 8, 2019. HPS3 was first reported in relation to Hermasky-Pudlak syndrome 3 in 2001 (Anikster, 2001, PMID: 11455388; Huizing, 2001, PMID: 11590544). At least 19 unique variants including nonsense, splice site, frameshift and large deletions have been reported in humans. Missense variants are not very common. HPS3 is involved in organelle biogenesis associated with melanosomes, platelet dense granules, and lysosomes. Hermansky-Pudlak syndrome 3 is characterized by a mild phenotype compared to HPS1, with minimal hypopigmentation, ocular rather than oculocutaneous albinism and a mild bleeding diathesis (PMID: 20301464). It is generally not associated with pulmonary fibrosis or granulomatous colitis. Evidence supporting this gene-disease relationship includes case-level data, family data and experimental data. Summary of Case Level Data: 12 Points Variants in this gene have been reported in at least 7 probands in 5 publications (PMID: 11455388, 11590544, 28284561, 27593200, 30791930). Variants in the gene segregated with 4 additional family members (PMID: 11455388). More evidence is available in the literature, but the maximum score for genetic evidence (12 pts) has been reached. The mechanism for disease is homozygous loss of function (PMID: 20301464) Summary of Experimental Data: 5 Points This gene-disease association is supported by mouse models and in vitro functional assays. The "cocoa" or "coa" mouse that carries at least 4 diferent spontaneously occurring mutations in the mouse Hps3 gene recapitulates the human HPS phenotype (PMID: 11707070, 14718540). HPS3 interacts with HPS5 and HPS6 to form BLOC-2, which is involved in the biogenesis of lysosome-related organelles (PMID: 15675963, 15632015, 15030569, 14718540). In summary, HPS3 is definitively associated with autosomal recessive Hermasky-Pudlak syndrome 3. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Hemostasis/Thrombosis GCEP on February 26, 2020 (SOP Version 6).

Hermansky-Pudlak syndrome 3STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013555

Submitter: PanelApp Australia

Hermansky-Pudlak syndrome 3DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0013555

Submitter: G2P

Hermansky-Pudlak syndrome 3STRONG

Inheritance Pattern: AR

Disease ID:MONDO:0013555

Submitter: Labcorp Genetics (formerly Invitae)

Hermansky-Pudlak syndrome 3DEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0013555

Submitter: Natera

Clinical Genomic Database (CGD)

Hermansky-Pudlak syndrome 3AR

Manifestation: Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Ophthalmologic; Pulmonary

Intervention: Allergy/Immunology/Infectious; Dermatologic; Gastrointestinal; Hematologic; Ophthalmologic

Rationale: Prevention and treatment of bleeding episodes (eg, with DDAVP or platelet/RBC transfusions) can be effective, and aspirin-containing products should be avoided; Skin surveillance and protection can be beneficial; Prompt treatment of pulmonary infections (as well as avoidance of cigarette smoke) to maximize pulmonary function is indicated, including influenza and pneumococcus vaccination; Surveillance related to ophthalmologic, gastrointestinal, and other manifestations has been recommended in all individuals with HPS

Refs: 11455388; 20301464Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to HPS3 variants in ClinVar

11 Conditions Cataloged
not providedTotal: 1068
Hermansky-Pudlak syndrome 3Total: 346
Hermansky-Pudlak syndromeTotal: 186
Inborn genetic diseasesTotal: 140
not specifiedTotal: 79
HPS3-related disorderTotal: 38
HPS3-related disordersTotal: 7
ThrombocytopeniaTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_032383.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
14
clinvar
414
clinvar
1
clinvar
429
missense
3
clinvar
357
clinvar
22
clinvar
2
clinvar
384
nonsense
55
clinvar
55
clinvar
110
start loss
1
clinvar
1
clinvar
1
clinvar
3
frameshift
129
clinvar
95
clinvar
2
clinvar
226
splice donor/acceptor (+/-2bp)
7
clinvar
34
clinvar
7
clinvar
48
Total19218838143631200

Highest pathogenic variant AF is 0.000099185905

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 47 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_032383.5RefSeqNP_115759.217MANE Select
ENST00000296051.7EnsemblENSP00000296051.217MANE Select
NM_001308258.2RefSeqNP_001295187.116Standard
ENST00000460120.5EnsemblENSP00000418230.116Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • organelle organization
  • pigmentation

Molecular Function

  • protein binding

Cellular Component

  • cytoplasm
  • BLOC-2 complex

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000296051
Coding exons
17
Length
44149
Individuals with no LoFs
125593
Homozygous LoFs
0
Heterozygous LoFs
155
Defined
125748
p
0.000616
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.1605255350.9810.00002776529
Missense (PolyPhen)263276.530.951073491
Synonymous-0.3782152081.030.00001101927
Loss of Function1.443848.90.7780.00000239641

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000620.00062rare
Latino/Admixed American0.000150.00014rare
Ashkenazi Jewish0.00180.0018notable
East Asian0.00160.0016notable
Finnish0.0000930.000092rare
European (Non-Finnish)0.000500.00050rare
South Asian0.00100.0010notable
Other0.000490.00049rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Involved in early stages of melanosome biogenesis and maturation. {ECO:0000250|UniProtKB:Q91VB4}.;

Recessive Scores

pRec
0.164

Intolerance Scores

LoFtool
0.961
RVIS EVS
-1.28
RVIS percentile EVS
5.13

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.128

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.